Y. Hisada, J. Geddings, C. Ay, and N. Mackman, Venous thrombosis and cancer: from mouse models to clinical trials, Journal of Thrombosis and Haemostasis, vol.22, issue.Suppl., pp.1372-82, 2015.
DOI : 10.3747/co.22.2392
URL : http://onlinelibrary.wiley.com/doi/10.1111/jth.13009/pdf

H. Chew, T. Wun, D. Harvey, H. Zhou, and R. White, Incidence of Venous Thromboembolism and Its Effect on Survival Among Patients With Common Cancers, Archives of Internal Medicine, vol.166, issue.4, pp.458-64, 2006.
DOI : 10.1001/archinte.166.4.458

A. Epstein, G. Soff, M. Capanu, C. Crosbie, M. Shah et al., Analysis of incidence and clinical outcomes in patients with thromboembolic events and invasive exocrine pancreatic cancer, Cancer, vol.20, issue.15 suppl, pp.3053-61, 2012.
DOI : 10.1002/sim.888

M. Mandalà, M. Reni, S. Cascinu, S. Barni, I. Floriani et al., Venous thromboembolism predicts poor prognosis in irresectable pancreatic cancer patients, Annals of Oncology, vol.18, issue.10, pp.1660-1665, 2007.
DOI : 10.1093/annonc/mdm284

L. Menapace, D. Peterson, A. Berry, T. Sousou, and A. Khorana, Summary, Thrombosis and Haemostasis, vol.106, issue.08, pp.371-379, 2011.
DOI : 10.1160/TH10-12-0789

M. Ouaissi, C. Frasconi, D. Mege, L. Panicot-dubois, L. Boiron et al., Impact of venous thromboembolism on the natural history of pancreatic adenocarcinoma, Hepatobiliary & Pancreatic Diseases International, vol.14, issue.4, pp.436-478, 2015.
DOI : 10.1016/S1499-3872(15)60397-6

A. Khorana, C. Francis, K. Menzies, J. Wang, O. Hyrien et al., Plasma tissue factor may be predictive of venous thromboembolism in pancreatic cancer, Journal of Thrombosis and Haemostasis, vol.104, issue.11, pp.1983-1988, 2008.
DOI : 10.1161/01.CIR.101.8.841

A. Piccin, W. Murphy, and O. Smith, Circulating microparticles: pathophysiology and clinical implications, Blood Reviews, vol.21, issue.3, pp.157-71, 2007.
DOI : 10.1016/j.blre.2006.09.001

N. Barteneva, E. Fasler-kan, M. Bernimoulin, J. Stern, E. Ponomarev et al., Circulating microparticles: square the circle, BMC Cell Biology, vol.14, issue.1, p.23, 2013.
DOI : 10.1128/IAI.01171-09
URL : https://bmccellbiol.biomedcentral.com/track/pdf/10.1186/1471-2121-14-23?site=bmccellbiol.biomedcentral.com

G. Thomas, L. Panicot-dubois, R. Lacroix, F. Dignat-george, D. Lombardo et al., Cancer cell???derived microparticles bearing P-selectin glycoprotein ligand 1 accelerate thrombus formation in vivo, The Journal of Experimental Medicine, vol.327, issue.9, pp.1913-1940, 2009.
DOI : 10.1016/j.critrevonc.2007.01.001

A. Owens and N. Mackman, Microparticles in Hemostasis and Thrombosis, Circulation Research, vol.108, issue.10, pp.1284-97, 2011.
DOI : 10.1161/CIRCRESAHA.110.233056
URL : http://circres.ahajournals.org/content/circresaha/108/10/1284.full.pdf

F. Woei-a-jin, M. Tesselaar, G. Rodriguez, P. Romijn, F. Bertina et al., Tissue factor-bearing microparticles and CA19.9: two players in pancreatic cancer-associated thrombosis?, British Journal of Cancer, vol.62, issue.3, pp.332-340, 2016.
DOI : 10.1158/1078-0432.CCR-09-0371

E. Campello, L. Spiezia, C. Radu, C. Bulato, M. Castelli et al., Endothelial, platelet, and tissue factor-bearing microparticles in cancer patients with and without venous thromboembolism, Thrombosis Research, vol.127, issue.5, pp.473-480, 2011.
DOI : 10.1016/j.thromres.2011.01.002

L. Zhao, Y. Bi, J. Kou, J. Shi, and D. Piao, Phosphatidylserine exposing-platelets and microparticles promote procoagulant activity in colon cancer patients, Journal of Experimental & Clinical Cancer Research, vol.93, issue.Suppl 1, p.54, 2016.
DOI : 10.1016/S0140-6736(10)61543-7
URL : http://doi.org/10.1186/s13046-016-0328-9

C. Yang, R. Ma, T. Jiang, M. Cao, L. Zhao et al., Contributions of phosphatidylserine-positive platelets and leukocytes and microparticles to hypercoagulable state in gastric cancer patients, Tumor Biology, vol.100, issue.Suppl 2, pp.7881-91, 2016.
DOI : 10.1182/blood-2002-01-0108

G. Hron, M. Kollars, H. Weber, V. Sagaster, P. Quehenberger et al., Tissue factorpositive microparticles: cellular origin and association with coagulation activation in patients with colorectal cancer, Thromb Haemost, vol.97, pp.119-142, 2007.

J. Thaler, S. Koder, G. Kornek, I. Pabinger, and C. Ay, Microparticle-associated tissue factor activity in patients with metastatic pancreatic cancer and its effect on fibrin clot formation, Translational Research, vol.163, issue.2, pp.145-50, 2014.
DOI : 10.1016/j.trsl.2013.06.009

K. Haubold, M. Rink, B. Spath, M. Friedrich, F. Chun et al., Tissue factor procoagulant activity of plasma microparticles is increased in patients with early-stage prostate cancer, Thrombosis and Haemostasis, vol.101, pp.1147-55, 2009.
DOI : 10.1160/TH08-10-0654

D. Manly, J. Wang, S. Glover, R. Kasthuri, H. Liebman et al., Increased microparticle tissue factor activity in cancer patients with Venous Thromboembolism, Thrombosis Research, vol.125, issue.6, pp.511-513, 2010.
DOI : 10.1016/j.thromres.2009.09.019
URL : http://europepmc.org/articles/pmc2878897?pdf=render

J. Zwicker, H. Liebman, D. Neuberg, R. Lacroix, K. Bauer et al., Tumor-Derived Tissue Factor-Bearing Microparticles Are Associated With Venous Thromboembolic Events in Malignancy, Clinical Cancer Research, vol.15, issue.22, pp.6830-6870, 2009.
DOI : 10.1158/1078-0432.CCR-09-0371
URL : http://clincancerres.aacrjournals.org/content/clincanres/15/22/6830.full.pdf

M. Tesselaar, F. Romjin, I. Van-der-linden, F. Prins, R. Bertina et al., Microparticle-associated tissue factor activity: a link between cancer and thrombosis?, Journal of Thrombosis and Haemostasis, vol.112, issue.3, pp.520-527, 2007.
DOI : 10.1172/JCI200318882

D. Mege, L. Panicot-dubois, M. Ouaissi, S. Robert, I. Sielezneff et al., The origin and concentration of circulating microparticles differ according to cancer type and evolution: A prospective single-center study, International Journal of Cancer, vol.96, issue.Suppl 2, pp.939-987, 2015.
DOI : 10.1038/sj.bjc.6603518
URL : https://hal.archives-ouvertes.fr/hal-01460678

R. Lacroix, C. Judicone, M. Mooberry, M. Boucekine, N. Key et al., Standardization of pre-analytical variables in plasma microparticle determination: results of the International Society on Thrombosis and Haemostasis SSC Collaborative workshop, Journal of Thrombosis and Haemostasis, vol.10, issue.6, 2013.
DOI : 10.1111/jth.12012

S. Robert, R. Lacroix, P. Poncelet, K. Harhouri, T. Bouriche et al., High-Sensitivity Flow Cytometry Provides Access to Standardized Measurement of Small-Size Microparticles--Brief Report, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.32, issue.4, pp.1054-1062, 2012.
DOI : 10.1161/ATVBAHA.111.244616

J. Thaler, C. Ay, N. Mackman, R. Bertina, A. Kaider et al., Microparticle-associated tissue factor activity, venous thromboembolism and mortality in pancreatic, gastric, colorectal and brain cancer patients, Journal of Thrombosis and Haemostasis, vol.6, issue.Suppl. 2, pp.1363-70, 2012.
DOI : 10.1111/j.1538-7836.2008.02987.x

M. Tesselaar, F. Romjin, I. Van-der-linden, R. Bertina, and S. Osanto, Microparticle-associated tissue factor activity in cancer patients with and without thrombosis, Journal of Thrombosis and Haemostasis, vol.6, issue.8, pp.1421-1424, 2009.
DOI : 10.1111/j.1538-7836.2009.03504.x

D. Mege, S. Cammilleri, O. Mundler, F. Dignat-george, C. Dubois et al., Circulating microparticles bearing Fibrin associated with whole-body 18FDG-PET: diagnostic tools to detect paraneoplastic polymyalgia rheumatica, Rheumatology International, vol.206, issue.9, pp.1099-103, 2016.
DOI : 10.1084/jem.20082297
URL : https://hal.archives-ouvertes.fr/hal-01425508

D. Fong, M. Steurer, P. Obrist, V. Barbieri, R. Margreiter et al., Ep-CAM expression in pancreatic and ampullary carcinomas: frequency and prognostic relevance, Journal of Clinical Pathology, vol.61, issue.1, pp.31-35, 2008.
DOI : 10.1136/jcp.2006.037333

E. Roca, R. Lacroix, C. Judicone, S. Laroumagne, S. Robert et al., Detection of EpCAMpositive microparticles in pleural fluid: a new approach to mini-invasively identify patients with malignant pleural effusions, Oncotarget, vol.7, pp.3357-66, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01455550

Y. Man, Y. Wang, J. Hao, X. Liu, C. Liu et al., Pretreatment Plasma D-Dimer, Fibrinogen, and Platelet Levels Significantly Impact Prognosis in Patients With Epithelial Ovarian Cancer Independently of Venous Thromboembolism, International Journal of Gynecological Cancer, vol.25, issue.1, pp.24-32, 2015.
DOI : 10.1097/IGC.0000000000000303

S. Erdem, A. Amasyali, O. Aytac, K. Onem, H. Issever et al., Increased preoperative levels of plasma fibrinogen and d dimer in patients with renal cell carcinoma is associated with poor survival and adverse tumor characteristics, Urologic Oncology: Seminars and Original Investigations, vol.32, issue.7, pp.1031-1071, 2014.
DOI : 10.1016/j.urolonc.2014.03.013

A. Desch, C. Gebhardt, J. Utikal, and S. Schneider, D-dimers in malignant melanoma: Association with prognosis and dynamic variation in disease progress, International Journal of Cancer, vol.130, issue.1, pp.914-921, 2017.
DOI : 10.1038/jid.2010.136

R. Lacroix, C. Judicone, P. Poncelet, S. Robert, L. Arnaud et al., Impact of pre-analytical parameters on the measurement of circulating microparticles: towards standardization of protocol, Journal of Thrombosis and Haemostasis, vol.20, issue.3, pp.437-483, 2012.
DOI : 10.1097/MBC.0b013e32831be9c5